Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Bladder Cancer

  Free Subscription


08.07.2019

1 Actas Urol Esp
1 Anticancer Res
1 Biosci Rep
1 BMC Cancer
3 BMJ Case Rep
1 Cancer Lett
1 Cancer Med
1 Cancer Sci
1 Cancers (Basel)
1 Clin Cancer Res
1 Curr Med Sci
1 Eur Urol
1 Exp Oncol
1 Front Oncol
1 Gene
1 Int J Mol Sci
1 Int J Oncol
1 J Cancer Res Clin Oncol
1 J Urol
1 Life Sci
1 Mol Carcinog
1 Mol Med Rep
1 Nat Med
3 Pathol Oncol Res
1 Scand J Urol
3 Urol Oncol
1 Urologia
1 Urology
1 Virchows Arch
2 World J Urol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Actas Urol Esp

  1. KRAJEWSKI W, Rodriguez-Faba O, Breda A, Pisano F, et al
    The 1973 WHO and 2004 WHO grading systems are not equal in prediction of survival among stage T1 bladder cancer patients.
    Actas Urol Esp. 2019 Jul 2. pii: S0210-4806(19)30100.
    PubMed     Text format     Abstract available


    Anticancer Res

  2. CHIANG CH, Yeh CY, Chung JG, Chiang IT, et al
    Amentoflavone Induces Apoptosis and Reduces Expression of Anti-apoptotic and Metastasis-associated Proteins in Bladder Cancer.
    Anticancer Res. 2019;39:3641-3649.
    PubMed     Text format     Abstract available


    Biosci Rep

  3. LI Y, Zhang X, Zhou X, Zhang X, et al
    LHPP suppresses the bladder cancer cell proliferation and growth via inactivating AKT/p65 signaling pathway.
    Biosci Rep. 2019 Jul 1. pii: BSR20182270. doi: 10.1042/BSR20182270.
    PubMed     Text format     Abstract available


    BMC Cancer

  4. TRILLA-FUERTES L, Gamez-Pozo A, Prado-Vazquez G, Zapater-Moros A, et al
    Biological molecular layer classification of muscle-invasive bladder cancer opens new treatment opportunities.
    BMC Cancer. 2019;19:636.
    PubMed     Text format     Abstract available


    BMJ Case Rep

  5. CHAN VSH, Chan DLH, Hui SY, Lam WWM, et al
    Occult extra-adrenal pheochromocytoma in the urinary bladder.
    BMJ Case Rep. 2019;12.
    PubMed     Text format    

  6. MUJUKIAN A, Innamaa A, Lippiatt J, Melson L, et al
    Extensive extramammary Paget's disease of the vulva involving the bladder postradical split skin graft reconstruction.
    BMJ Case Rep. 2019;12.
    PubMed     Text format    

  7. PEREIRA R, Perera M, Rhee H
    Metastatic plasmacytoid bladder cancer causing malignant priapism.
    BMJ Case Rep. 2019;12.
    PubMed     Text format     Abstract available


    Cancer Lett

  8. ZHENG F, Wang M, Li Y, Huang C, et al
    CircNR3C1 inhibits proliferation of bladder cancer cells by sponging miR-27a-3p and downregulating cyclin D1 expression.
    Cancer Lett. 2019 Jun 27. pii: S0304-3835(19)30379.
    PubMed     Text format     Abstract available


    Cancer Med

  9. LI F, Yang C, Zhang HB, Ma J, et al
    BET inhibitor JQ1 suppresses cell proliferation via inducing autophagy and activating LKB1/AMPK in bladder cancer cells.
    Cancer Med. 2019 Jun 28. doi: 10.1002/cam4.2385.
    PubMed     Text format     Abstract available


    Cancer Sci

  10. ELBADAWY M, Usui T, Mori T, Tsunedomi R, et al
    Establishment of a novel experimental model for muscle-invasive bladder cancer by using dog bladder cancer organoid culture.
    Cancer Sci. 2019 Jun 29. doi: 10.1111/cas.14118.
    PubMed     Text format     Abstract available


    Cancers (Basel)

  11. LORAS A, Martinez-Bisbal MC, Quintas G, Gil S, et al
    Urinary Metabolic Signatures Detect Recurrences in Non-Muscle Invasive Bladder Cancer.
    Cancers (Basel). 2019;11.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  12. ANNELS NE, Mansfield D, Arif M, Ballesteros-Merino C, et al
    Viral targeting of non-muscle invasive bladder cancer and priming of anti-tumour immunity following intravesical Coxsackievirus A21.
    Clin Cancer Res. 2019 Jul 4. pii: 1078-0432.CCR-18-4022.
    PubMed     Text format     Abstract available


    Curr Med Sci

  13. XIAO J, Wang M, He W, Wang J, et al
    Does Postoperative Rehabilitation for Radical Cystectomy Call for Enhanced Recovery after Surgery? A Systematic Review and Meta-analysis.
    Curr Med Sci. 2019;39:99-110.
    PubMed     Text format     Abstract available


    Eur Urol

  14. KETTUNEN K, Bostrom PJ, Lamminen T, Heinosalo T, et al
    Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells.
    Eur Urol. 2019 Jun 27. pii: S0302-2838(19)30501.
    PubMed     Text format     Abstract available


    Exp Oncol

  15. YAKOVLEV PG, Klyushin DA, Vereshchako RI
    Bladder sparing surgery in high-grade bladder cancer.
    Exp Oncol. 2019;41:160-165.
    PubMed     Text format     Abstract available


    Front Oncol

  16. ZHANG G, Wang Q, Yang M, Yuan Q, et al
    OSblca: A Web Server for Investigating Prognostic Biomarkers of Bladder Cancer Patients.
    Front Oncol. 2019;9:466.
    PubMed     Text format     Abstract available


    Gene

  17. CHEN X, Wang P, Wang S, Li J, et al
    CIZ1 knockdown suppresses the proliferation of bladder cancer cells by inducing apoptosis.
    Gene. 2019 Jun 25:143946. doi: 10.1016/j.gene.2019.143946.
    PubMed     Text format     Abstract available


    Int J Mol Sci

  18. HSU FS, Wu JT, Lin JY, Yang SP, et al
    Histone Deacetylase Inhibitor, Trichostatin A, Synergistically Enhances Paclitaxel-Induced Cytotoxicity in Urothelial Carcinoma Cells by Suppressing the ERK Pathway.
    Int J Mol Sci. 2019;20.
    PubMed     Text format     Abstract available


    Int J Oncol

  19. MORAN JD, Kim HH, Li Z, Moreno CS, et al
    SOX4 regulates invasion of bladder cancer cells via repression of WNT5a.
    Int J Oncol. 2019 Jun 26. doi: 10.3892/ijo.2019.4832.
    PubMed     Text format     Abstract available


    J Cancer Res Clin Oncol

  20. CHIRIFE AM, Villasante N, Rojas Bilbao E, Casas G, et al
    Individual patient risk of progression of urinary bladder papillary tumors estimated from biomarkers at initial transurethral resection of bladder tumor.
    J Cancer Res Clin Oncol. 2019;145:1709-1718.
    PubMed     Text format     Abstract available


    J Urol

  21. KUROIWA K, Inokuchi J, Nishiyama H, Kojima T, et al
    Impact of Previous, Simultaneous or Subsequent Bladder Cancer on Prognosis after Radical Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma.
    J Urol. 2019 Jun 28:101097JU0000000000000422. doi: 10.1097/JU.0000000000000422.
    PubMed     Text format     Abstract available


    Life Sci

  22. HUAQI Y, Caipeng Q, Qiang W, Yiqing D, et al
    The role of SOX18 in bladder cancer and its underlying mechanism in mediating cellular functions.
    Life Sci. 2019 Jun 28:116614. doi: 10.1016/j.lfs.2019.116614.
    PubMed     Text format     Abstract available


    Mol Carcinog

  23. XU J, Hua X, Jin H, Zhu J, et al
    NFkappaB2 p52 stabilizes rhogdibeta mRNA by inhibiting AUF1 protein degradation via a miR-145/Sp1/USP8-dependent axis.
    Mol Carcinog. 2019;58:777-793.
    PubMed     Text format     Abstract available


    Mol Med Rep

  24. WANG W, Xu Z, Wang J, Chen R, et al
    LINC00978 promotes bladder cancer cell proliferation, migration and invasion by sponging miR4288.
    Mol Med Rep. 2019;20:1866-1872.
    PubMed     Text format     Abstract available


    Nat Med

  25. SEGOVIA C, San Jose-Eneriz E, Munera-Maravilla E, Martinez-Fernandez M, et al
    Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression.
    Nat Med. 2019 Jul 3. pii: 10.1038/s41591-019-0499.
    PubMed     Text format     Abstract available


    Pathol Oncol Res

  26. GAO BS, Rong CS, Xu HM, Sun T, et al
    Peptidyl Arginine Deiminase, Type II (PADI2) Is Involved in Urothelial Bladder Cancer.
    Pathol Oncol Res. 2019 Jul 2. pii: 10.1007/s12253-019-00687.
    PubMed     Text format     Abstract available

  27. KRAFFT U, Tschirdewahn S, Hess J, Harke NN, et al
    STIP1 Tissue Expression Is Associated with Survival in Chemotherapy-Treated Bladder Cancer Patients.
    Pathol Oncol Res. 2019 Jun 27. pii: 10.1007/s12253-019-00689.
    PubMed     Text format     Abstract available

  28. RAKHSHAN A, Esmaeili MH, Kahaei MS, Taheri M, et al
    A Single Nucleotide Polymorphism in GAS5 lncRNA is Associated with Risk of Bladder Cancer in Iranian Population.
    Pathol Oncol Res. 2019 Jun 27. pii: 10.1007/s12253-019-00693.
    PubMed     Text format     Abstract available


    Scand J Urol

  29. MALMSTROM PU, Gardmark T, Sherif A, Strock V, et al
    Incidence, survival and mortality trends of bladder cancer in Sweden 1997-2016.
    Scand J Urol. 2019 Jul 2:1-7. doi: 10.1080/21681805.2019.1632380.
    PubMed     Text format     Abstract available


    Urol Oncol

  30. DANIELS MJ, Barry E, Schoenberg M, Lamm DL, et al
    Contemporary oncologic outcomes of second induction course BCG in patients with nonmuscle invasive bladder cancer.
    Urol Oncol. 2019 Jun 26. pii: S1078-1439(19)30218.
    PubMed     Text format     Abstract available

  31. TSAI YS, Jou YC, Tsai HT, Cheong IS, et al
    Indoleamine-2,3-dioxygenase-1 expression predicts poorer survival and up-regulates ZEB2 expression in human early stage bladder cancer.
    Urol Oncol. 2019 Jun 25. pii: S1078-1439(19)30191.
    PubMed     Text format     Abstract available

  32. IWATA T, Kimura S, Abufaraj M, Janisch F, et al
    Prognostic role of the urokinase plasminogen activator (uPA) system in patients with nonmuscle invasive bladder cancer.
    Urol Oncol. 2019 Jun 26. pii: S1078-1439(19)30219.
    PubMed     Text format     Abstract available


    Urologia

  33. RICCARDI N, Ferrarese M, Castellotti P, Mazzola E, et al
    A rare case of multi-focal human TB after BCG instillation for non-muscle-invasive bladder cancer.
    Urologia. 2019 Jul 4:391560319860396. doi: 10.1177/0391560319860396.
    PubMed     Text format     Abstract available


    Urology

  34. TOBERT CM, Nepple KG, McDowell BD, Charlton ME, et al
    COMPLIANCE WITH AMERICAN UROLOGICAL ASSOCIATION GUIDELINES FOR NON-MUSCLE INVASIVE BLADDER CANCER REMAINS POOR: ASSESSING FACTORS ASSOCIATED WITH NON-COMPLIANCE AND SURVIVAL IN A RURAL STATE.
    Urology. 2019 Jun 25. pii: S0090-4295(19)30562.
    PubMed     Text format     Abstract available


    Virchows Arch

  35. SCHWAMBORN K, Ammann JU, Knuchel R, Hartmann A, et al
    Multicentric analytical comparability study of programmed death-ligand 1 expression on tumor-infiltrating immune cells and tumor cells in urothelial bladder cancer using four clinically developed immunohistochemistry assays.
    Virchows Arch. 2019 Jul 2. pii: 10.1007/s00428-019-02610.
    PubMed     Text format     Abstract available


    World J Urol

  36. TAN TW, Nair R, Saad S, Thurairaja R, et al
    Safe transition from extracorporeal to intracorporeal urinary diversion following robot-assisted cystectomy: a recipe for reducing operative time, blood loss and complication rates.
    World J Urol. 2019;37:367-372.
    PubMed     Text format     Abstract available

  37. FROEHNER M, Koch R, Heberling U, Hubler M, et al
    Which comorbidity classification is best suited to identify patients at risk for 90-day and long-term non-bladder cancer mortality after radical cystectomy?
    World J Urol. 2019 Jul 2. pii: 10.1007/s00345-019-02860.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: